State Street
ATOS icon

State Street’s Atossa Therapeutics ATOS Stock Holding History

State Street’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.7K Hold
39,761
– – ﹤0.01% 4003
2026
Q1 		$209K Sell
39,761
-5
-0% -$32 ﹤0.01% 3874
2025
Q4 		$352K Buy
39,766
+9,466
+31% +$120K ﹤0.01% 3773
2025
Q3 		$394K Sell
30,300
-4,138
-12% -$51.1K ﹤0.01% 3716
2025
Q2 		$429K Sell
34,438
-80,701
-70% -$965K ﹤0.01% 3651
2025
Q1 		$1.16M Sell
115,139
-1,886
-2% -$22.9K ﹤0.01% 3396
2024
Q4 		$1.66M Buy
117,025
+1,544
+1% +$30.1K ﹤0.01% 3377
2024
Q3 		$2.63M Buy
115,481
+4,612
+4% +$93.1K ﹤0.01% 3227
2024
Q2 		$1.98M Buy
110,869
+77,964
+237% +$1.72M ﹤0.01% 3322
2024
Q1 		$888K Buy
32,905
+3,820
+13% +$61.3K ﹤0.01% 3501
2023
Q4 		$384K Hold
29,085
– – ﹤0.01% 3708
2023
Q3 		$321K Hold
29,085
– – ﹤0.01% 3786
2023
Q2 		$550K Sell
29,085
-2,981
-9% -$36.1K ﹤0.01% 3666
2023
Q1 		$349K Hold
32,066
– – ﹤0.01% 3876
2022
Q4 		$254K Hold
32,066
– – ﹤0.01% 4013
2022
Q3 		$401K Hold
32,066
– – ﹤0.01% 3861
2022
Q2 		$524K Sell
32,066
-116,801
-78% -$1.84M ﹤0.01% 3812
2022
Q1 		$2.79M Buy
148,867
+6,064
+4% +$123K ﹤0.01% 3441
2021
Q4 		$3.43M Sell
142,803
-260
-0.2% -$9.52K ﹤0.01% 3422
2021
Q3 		$7M Buy
143,063
+7,552
+6% +$439K ﹤0.01% 3065
2021
Q2 		$12.8M Buy
+135,511
New +$7.17M ﹤0.01% 2772

Other funds holding ATOS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street's ATOS Position: Q2 2026 in Review

State Street held its Atossa Therapeutics (ATOS) position steady in Q2 2026 at 39,761 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4003.

State Street first reported a position in ATOS in Q2 2021 and has held it in 21 quarters since. The position peaked at $12.8M in Q2 2021. 31 funds tracked by Wall St. Rank hold ATOS as of Q2 2026.

  • State Street held 39,761 shares of Atossa Therapeutics worth $76.7K as of Q2 2026.
  • State Street left its Atossa Therapeutics share count unchanged in Q2 2026.
  • Atossa Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4003 holding.
  • State Street first reported a position in Atossa Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • State Street's Atossa Therapeutics position peaked at $12.8M in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.